Status:
NOT_YET_RECRUITING
Development of a Rapid Diagnostic Test to Identify Crimean-Congo Hemorrhagic Fever - Research and Development Testing
Lead Sponsor:
Liverpool School of Tropical Medicine
Collaborating Sponsors:
Ondokuz Mayıs University
Cumhuriyet University
Conditions:
Infectious Diseases, Emerging
Eligibility:
All Genders
18+ years
Brief Summary
Background Crimean-Congo Haemorrhagic Fever (CCHF) is a rare disease with a death rate between 10% and 50%, rising to 80% during outbreaks. There are no approved drugs or vaccines, and existing treatm...
Detailed Description
Background Crimean-Congo Haemorrhagic Fever (CCHF) is a life-threatening disease with a fatality rate ranging from 10% to 50%, and up to 80% in outbreaks. Despite its severity, there are no licensed d...
Eligibility Criteria
Inclusion
- Willing to give whole blood samples (in a serum tube and EDTA tube) suspected of CCHF from Türkiye, Department of Infectious Diseases and Clinical Microbiology, Medical Faculty, Sivas Cumhuriyet University, Sivas or the department of Infectious Diseases or Ondokuz Mayis University (OMU) Faculty of Medicine, Department of Clinical Microbiology and Infectious Diseases, Samsun, that have not been frozen or refrigerated.
- Adults aged 18 or over.
Exclusion
- None
Key Trial Info
Start Date :
May 1 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
November 1 2025
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT06894758
Start Date
May 1 2025
End Date
November 1 2025
Last Update
March 25 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Ondokuz Mayis University (OMU) Faculty of Medicine, Department of Clinical Microbiology and Infectious Diseases, Samsun
Samsun, Turkey (Türkiye), 55200
2
Department of Infectious Diseases and Clinical Microbiology, Medical Faculty, Sivas Cumhuriyet University, Sivas
Sivas, Turkey (Türkiye), 58000